drugset / Trial / NCT02289391

Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia

NCT02289391

RandomizedParallel-groupDouble-blindPrevention

Summary

The study try to illustrate the possible mechanisms of tending to induce airway spasms and the impact of dexmedetomidine on inflammatory reaction in general anesthesia patients with asthma,by detecting the differences of plasma inflammatory factor interleukin(IL)-4, IL-5, IL-13, IL-17, IL-33, MBP and immunoglobulin E(IgE) levels between asthma patients and non-asthma patients.

Timeline

Start
2014-12
Primary completion
2015-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg
Background Atracurium Small molecule 0.05 mg/kg Intravenous
Background Cisatracurium Small molecule 0.15 mg/kg Intravenous
Background Etomidate Small molecule 0.2 mg/kg Intravenous
Background Fentanyl Other / unclassified 4 ug/kg Intravenous
Background Midazolam Small molecule 0.05 mg/kg Intravenous
Background Propofol Small molecule 3 mg/kg Intravenous
Background Propofol Small molecule 8 mg/kg Intravenous
Background Remifentanil Small molecule 0.2 ug/kg Intravenous

Indications